2.8326
price down icon0.96%   -0.0274
 
loading
Neuraxis Inc stock is traded at $2.8326, with a volume of 9,173. It is down -0.96% in the last 24 hours and up +19.52% over the past month. NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
See More
Previous Close:
$2.86
Open:
$2.8568
24h Volume:
9,173
Relative Volume:
0.01
Market Cap:
$20.55M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-3.5118
EPS:
-0.8066
Net Cash Flow:
-
1W Performance:
+19.52%
1M Performance:
+19.52%
6M Performance:
-6.21%
1Y Performance:
-9.21%
1-Day Range:
Value
$2.8125
$2.8901
1-Week Range:
Value
$2.42
$2.92
52-Week Range:
Value
$1.33
$6.20

Neuraxis Inc Stock (NRXS) Company Profile

Name
Name
Neuraxis Inc
Name
Phone
(812) 689-0791
Name
Address
11550 North Meridian Street, Suite 325, Carmel
Name
Employee
17
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
NRXS's Discussions on Twitter

Compare NRXS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NRXS
Neuraxis Inc
2.8473 23.44M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.00 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
571.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.62 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
572.60 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.93 29.19B 3.81B -644.79M -669.77M -6.24

Neuraxis Inc Stock (NRXS) Latest News

pulisher
Jul 22, 2025

Is NeurAxis Inc. a good long term investmentSky-high profits - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives NeurAxis Inc. stock priceConsistent high-yield stocks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

NeurAxis Inc. Stock Analysis and ForecastAccelerated profit realization - jammulinksnews.com

Jul 21, 2025
pulisher
Jul 20, 2025

What analysts say about NeurAxis Inc. stockFast-track wealth growth - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 18, 2025

is neuraxis inc. stock a growth or value play2x 3x 5x Pick Alert - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Why NeurAxis Inc. stock is on top investor watchlistsMinimized Risk Maximum Return - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Is NeurAxis Inc. stock a growth or value playFree Signals Group - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Published on: 2025-07-18 00:27:06 - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

How NeurAxis Inc. stock performs during market volatilityLow Risk Stock Strategies - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why NeurAxis Inc. stock attracts strong analyst attentionGrowth Optimized Stock Radar - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes NeurAxis Inc. stock price move sharplySteady Profit Stock Forecasts - Newser

Jul 15, 2025
pulisher
Jul 04, 2025

Thursday’s Insider Moves: Top Executives Make Strategic Trades - Investing.com Australia

Jul 04, 2025
pulisher
Jul 03, 2025

Major Shareholder Sells Massive Stake in NeurAxis, Inc. - TipRanks

Jul 03, 2025
pulisher
Jul 03, 2025

Neuraxis ends Masimo license agreement and launches employee stock plan - Investing.com

Jul 03, 2025
pulisher
Jul 03, 2025

Neuraxis Inc: Brian Hannasch buys $800k in shares - Investing.com

Jul 03, 2025
pulisher
Jul 03, 2025

Neuraxis Inc: Brian Hannasch buys $800k in shares By Investing.com - Investing.com Nigeria

Jul 03, 2025
pulisher
Jun 27, 2025

The Zacks Analyst Blog Highlights Microsoft, NVIDIA, Bank of America, BK Technologies and NeurAxis - Yahoo Finance

Jun 27, 2025
pulisher
Jun 26, 2025

Top Stock Reports for Microsoft, NVIDIA & Bank of America - TradingView

Jun 26, 2025
pulisher
Jun 17, 2025

Neuraxis announces new medical policy with two health insurers - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

NeurAxis, Inc. Expands Insurance Coverage for IB-Stim Therapy, Enhancing Access for Patients with Abdominal Pain - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

NeurAxis (NASDAQ:NRXS) Now Covered by Analysts at Craig Hallum - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Neuraxis (NRXS) Initiated with Buy Rating by Craig-Hallum | NRXS Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Craig-Hallum initiates NeurAxis stock with buy rating on pediatric device - Investing.com India

Jun 16, 2025
pulisher
Jun 16, 2025

Craig-Hallum bullish on Neuraxis, initiates with a Buy - TipRanks

Jun 16, 2025
pulisher
Jun 10, 2025

Neuraxis, Inc. Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain in Ibs - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

NeurAxis (NRXS) Gains Momentum with Key Guideline Inclusion | NR - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Neuraxis secures key academic society guidelines recommendation for FAP - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

NeurAxis Achieves Critical Milestone; Secures Key Academic - GlobeNewswire

Jun 10, 2025
pulisher
Jun 10, 2025

Major Medical Guidelines Back NeurAxis $3B IBS Treatment for Children, Only FDA-Cleared Option - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

47,094 Shares in NeurAxis, Inc. (NASDAQ:NRXS) Bought by Citadel Advisors LLC - Defense World

Jun 10, 2025

Neuraxis Inc Stock (NRXS) Financials Data

There is no financial data for Neuraxis Inc (NRXS). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$22.70
price up icon 4.20%
$35.91
price down icon 0.52%
$101.86
price down icon 0.93%
$27.68
price up icon 4.30%
$113.71
price up icon 2.09%
biotechnology ONC
$295.83
price up icon 0.07%
Cap:     |  Volume (24h):